Get a deeper insight into the potential performance of Edgewell Personal (EPC) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Beyond analysts' top -and-bottom-line estimates for PENN Entertainment (PENN), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.

Besides Wall Street's top -and-bottom-line estimates for Western Midstream (WES), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.

Evaluate the expected performance of Planet Fitness (PLNT) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Besides Wall Street's top -and-bottom-line estimates for Wolverine (WWW), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.

VNO's Q1 results reflect growth in same-store NOI, aided by higher leasing activity.

Recursion Pharmaceuticals stock falls due to weaker-than-expected first-quarter results, along with the abandonment of certain key pipeline programs.

Take-Two Interactive (NASDAQ: TTWO) stock began the Tuesday, May 6 session with uncertainty rapidly changing direction within minutes as Rockstar Games – one of its subsidiaries – released the second trailer for the upcoming Grand Theft Auto VI (GTA 6).

One analyst, Dan Ives of Wedbush, raised his price target on Palantir from $120 to $140 and predicted that it will have a one-trillion market cap within the next two to three years. If that's the case, PLTR stock will easily grow into its current valuation, and the stock price will likely be much higher.

Hims & Hers Health, Inc.'s Q1 2025 earnings show impressive growth, with revenues up 111% year-on-year and net income rising significantly, but HIMS shares dropped 8% pre-market. The company's success has been heavily tied to access to weight loss drugs like semaglutide; however, the end of the drug shortage period poses challenges. Hims' new partnership with Novo Nordisk aims to sustain growth, but competition from direct-to-consumer platforms raises concerns about long-term differentiation.

NET's Q1 results are likely to reflect benefits from expanding enterprise client base and AI-driven innovation.

Skyward (SKWD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Great Lakes Dredge & Dock (GLDD) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.31 per share a year ago.

Perdoceo Education (PRDO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Uniti Group (UNIT) came out with quarterly funds from operations (FFO) of $0.35 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.32 per share a year ago.

Krystal Biotech, Inc. (KRYS) came out with quarterly earnings of $1.20 per share, missing the Zacks Consensus Estimate of $1.38 per share. This compares to earnings of $0.03 per share a year ago.

NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Arvinas, Inc. ("Arvinas") (NASDAQ:ARVN) concerning possible violations of federal securities laws. On May 1, 2025, Arvinas issued a press release announcing a re-prioritization of its vepdegestrant development plan and research portfolio.

NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Agilysys, Inc. ("Agilysys, Inc.") (NASDAQ:AGYS) concerning possible violations of federal securities laws. On January 21, 2025, after the market closed, Agilysys issued a press release announcing third quarter revenue below expectations and the company's own guidance, resulting in a significant revision to Agilysys' FY25 revenue guidance.

NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Wabash National Corporation ("Wabash National") (NYSE:WNC) concerning possible violations of federal securities laws. On April 30, 2025, Wabash issued a press release announcing its financial results for Q1 of 2025.

NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of D-Wave Quantum Inc. ("D-Wave Quantum Inc.") (NYSE:QBTS) concerning possible violations of federal securities laws. On April 29, 2025, Kerrisdale Capital released a report on D-Wave Quantum Inc. Kerrisdale alleges that D-Wave Quantum's technology is "essentially a marketing gimmick" and that the company has "no credible plan to transition to a viable gate-model quantum computer.